Literature DB >> 32127668

GPCR agonist targets obesity and diabetes.

Sarah Crunkhorn.   

Abstract

Entities:  

Year:  2020        PMID： 32127668     DOI： 10.1038/d41573-020-00021-3

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Preclinical efficacy of the GPER-selective agonist G-1 in mouse models of obesity and diabetes.

Authors:  Geetanjali Sharma; Chelin Hu; Daniela I Staquicini; Jonathan L Brigman; Meilian Liu; Franck Mauvais-Jarvis; Renata Pasqualini; Wadih Arap; Jeffrey B Arterburn; Helen J Hathaway; Eric R Prossnitz
Journal:  Sci Transl Med       Date:  2020-01-29       Impact factor: 17.956
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.